| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |